BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24722473)

  • 1. T-cell regulation in lepromatous leprosy.
    Bobosha K; Wilson L; van Meijgaarden KE; Bekele Y; Zewdie M; van der Ploeg-van Schip JJ; Abebe M; Hussein J; Khadge S; Neupane KD; Hagge DA; Jordanova ES; Aseffa A; Ottenhoff TH; Geluk A
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2773. PubMed ID: 24722473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in TGF-β secreting CD4⁺CD25⁺ FOXP3⁺ T regulatory cells in anergic lepromatous leprosy patients.
    Saini C; Ramesh V; Nath I
    PLoS Negl Trop Dis; 2014; 8(1):e2639. PubMed ID: 24454972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppression.
    de Souza Sales J; Lara FA; Amadeu TP; de Oliveira Fulco T; da Costa Nery JA; Sampaio EP; Pinheiro RO; Sarno EN
    Clin Exp Immunol; 2011 Aug; 165(2):251-63. PubMed ID: 21592112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocity between Regulatory T Cells and Th17 Cells: Relevance to Polarized Immunity in Leprosy.
    Sadhu S; Khaitan BK; Joshi B; Sengupta U; Nautiyal AK; Mitra DK
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004338. PubMed ID: 26751584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced suppressor cell response to Mycobacterium leprae in lepromatous leprosy.
    Sasiain MD; de la Barrera S; Valdez R; Balina LM
    Infect Immun; 1989 Mar; 57(3):951-6. PubMed ID: 2521841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells in erythema nodosum leprosum maintain anti-inflammatory function.
    Negera E; Bobosha K; Aseffa A; Dockrell HM; Lockwood DNJ; Walker SL
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010641. PubMed ID: 35867720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of regulatory T cells and down-regulatory molecules in lepromatous leprosy.
    Palermo ML; Pagliari C; Trindade MA; Yamashitafuji TM; Duarte AJ; Cacere CR; Benard G
    Am J Trop Med Hyg; 2012 May; 86(5):878-83. PubMed ID: 22556091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.
    Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH
    Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens.
    Upadhyay R; Dua B; Sharma B; Natrajan M; Jain AK; Kithiganahalli Narayanaswamy B; Joshi B
    BMC Infect Dis; 2019 Jan; 19(1):52. PubMed ID: 30642265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium leprae reactive T cell clones from lepromatous leprosy patients after prolonged dapsone chemotherapy.
    Gill HK; Ridley DS; Ganesan J; Mustafa AS; Rees RJ; Godal T
    Lepr Rev; 1990 Mar; 61(1):25-31. PubMed ID: 2181222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
    J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients.
    Launois P; Huygen K; De Bruyn J; N'Diaye M; Diouf B; Sarthouj L; Grimaud J; Millan J
    Clin Exp Immunol; 1991 Nov; 86(2):286-90. PubMed ID: 1934596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
    Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals.
    Sampaio EP; Caneshi JR; Nery JA; Duppre NC; Pereira GM; Vieira LM; Moreira AL; Kaplan G; Sarno EN
    Infect Immun; 1995 May; 63(5):1848-54. PubMed ID: 7729894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Levels of Migration Inhibitory Factor (MIF) and
    Martinez-Guzman MA; Alvarado-Navarro A; Delgado-Rizo V; Garcia-Orozco A; Mayorga-Rodríguez JA; Pereira-Suarez AL; Fafutis-Morris M
    Front Immunol; 2018; 9():246. PubMed ID: 29487601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development.
    Sampaio LH; Stefani MM; Oliveira RM; Sousa AL; Ireton GC; Reed SG; Duthie MS
    BMC Infect Dis; 2011 Jan; 11():26. PubMed ID: 21269435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.